- Home
- FRPH vs EYPT Comparison
FRPH vs EYPT Comparison
Compare FRPH & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- EYPT
- Stock Information
- Founded
- FRPH 1986
- EYPT 1987
- Country
- FRPH United States
- EYPT United States
- Employees
- FRPH N/A
- EYPT N/A
- Industry
- FRPH Real Estate
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- FRPH Finance
- EYPT Industrials
- Exchange
- FRPH Nasdaq
- EYPT Nasdaq
- Market Cap
- FRPH 482.5M
- EYPT 741.0M
- IPO Year
- FRPH N/A
- EYPT 2005
- Fundamental
- Price
- FRPH $25.02
- EYPT $13.76
- Analyst Decision
- FRPH
- EYPT Strong Buy
- Analyst Count
- FRPH 0
- EYPT 6
- Target Price
- FRPH N/A
- EYPT $25.83
- AVG Volume (30 Days)
- FRPH 40.7K
- EYPT 823.7K
- Earning Date
- FRPH 11-05-2025
- EYPT 11-06-2025
- Dividend Yield
- FRPH N/A
- EYPT N/A
- EPS Growth
- FRPH N/A
- EYPT N/A
- EPS
- FRPH 0.28
- EYPT N/A
- Revenue
- FRPH $32,293,999.00
- EYPT $51,898,000.00
- Revenue This Year
- FRPH N/A
- EYPT N/A
- Revenue Next Year
- FRPH N/A
- EYPT N/A
- P/E Ratio
- FRPH $88.83
- EYPT N/A
- Revenue Growth
- FRPH 3.18
- EYPT 2.99
- 52 Week Low
- FRPH $24.72
- EYPT $3.91
- 52 Week High
- FRPH $33.00
- EYPT $14.42
- Technical
- Relative Strength Index (RSI)
- FRPH 42.63
- EYPT 66.97
- Support Level
- FRPH $24.75
- EYPT $12.88
- Resistance Level
- FRPH $25.49
- EYPT $14.15
- Average True Range (ATR)
- FRPH 0.43
- EYPT 0.76
- MACD
- FRPH -0.02
- EYPT 0.02
- Stochastic Oscillator
- FRPH 21.43
- EYPT 79.11
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.